SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis - Wikidata - awgldk - TriplyDB

SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis

SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis

http://www.wikidata.org/entity/Q34123761

about

Angiogenesis inhibitor vasohibin-1 enhances stress resistance of endothelial cells via induction of SOD2 and SIRT1 Epigenetic Control of Macrophage Polarisation and Soluble Mediator Gene Expression during Inflammation Sirtuins Link Inflammation and Metabolism Ginkgolide B reduces LOX-1 expression by inhibiting Akt phosphorylation and increasing Sirt1 expression in oxidized LDL-stimulated human umbilical vein endothelial cells Celastrol prevents atherosclerosis via inhibiting LOX-1 and oxidative stress Effects of the small molecule SIRT1 activator, SRT2104 on arterial stiffness in otherwise healthy cigarette smokers and subjects with type 2 diabetes mellitus Molecular mechanism of endothelial and vascular aging: implications for cardiovascular disease.SIRT1 mediates the protective function of Nkx2.5 during stress in cardiomyocytes.A novel model of cholesterol efflux from lipid-loaded cells ApoE-/- PGC-1α-/- mice display reduced IL-18 levels and do not develop enhanced atherosclerosis.Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity.SIRT1 reduces endothelial activation without affecting vascular function in ApoE-/- mice.LOX-1 in atherosclerosis: biological functions and pharmacological modifiers.Anti-inflammatory therapies for cardiovascular disease Sirt1 inhibits resistin expression in aortic stenosis Peripheral blood monocyte Sirt1 expression is reduced in patients with coronary artery disease.The Sirt1 activator SRT3025 provides atheroprotection in Apoe-/- mice by reducing hepatic Pcsk9 secretion and enhancing Ldlr expression.SIRT1-mediated epigenetic downregulation of plasminogen activator inhibitor-1 prevents vascular endothelial replicative senescence A TagSNP in SIRT1 gene confers susceptibility to myocardial infarction in a Chinese Han population.Sirtuins, aging, and cardiovascular risks.Regulation of Cell Cycle Regulators by SIRT1 Contributes to Resveratrol-Mediated Prevention of Pulmonary Arterial Hypertension.Involvement of miR-Let7A in inflammatory response and cell survival/apoptosis regulated by resveratrol in THP-1 macrophage.Metabolomic profiling of the heart during acute ischemic preconditioning reveals a role for SIRT1 in rapid cardioprotective metabolic adaptation.Protective effects of sirtuins in cardiovascular diseases: from bench to bedside The sirtuin family's role in aging and age-associated pathologies.Sirt1 is involved in decreased bone formation in aged apolipoprotein E-deficient mice.Sirtuins, Cell Senescence, and Vascular Aging SIRT1: recent lessons from mouse models.Cardiovascular effects of a novel SIRT1 activator, SRT2104, in otherwise healthy cigarette smokers.Potential mechanisms linking atherosclerosis and increased cardiovascular risk in COPD: focus on Sirtuins.SIRT6 protects against endothelial dysfunction and atherosclerosis in mice Identification of a SIRT1 mutation in a family with type 1 diabetes.SIRT1 is a Highly Networked Protein That Mediates the Adaptation to Chronic Physiological Stress.The protective role of Sirt1 in vascular tissue: its relationship to vascular aging and atherosclerosis.Deletion of Sirt3 does not affect atherosclerosis but accelerates weight gain and impairs rapid metabolic adaptation in LDL receptor knockout mice: implications for cardiovascular risk factor development.Enhancement in efferocytosis of oxidized low-density lipoprotein-induced apoptotic RAW264.7 cells through Sirt1-mediated autophagy.Translational research: lessons from past research, growing up nowadays, and development goal in future.Molecular biology of atherosclerosis.Poly(ADP-ribose) polymerase 1 (PARP1) in atherosclerosis: from molecular mechanisms to therapeutic implications.Mechanistic perspectives of calorie restriction on vascular homeostasis.

P2860

Q24300671-2409C3D7-DFDC-44A4-9EB1-A015CBBEF6A8 Q26753020-D2F9ADC0-764D-471F-8A64-19CDFFC743CA Q26767141-ACC3AAEE-859A-4332-9C52-D8EEF40FF404 Q28533547-0A02A8CF-D9DA-43AA-8905-F8C98166A6A2 Q28533974-E8B9DC37-23FB-4D53-B1CC-EF60A9CC14D4 Q28602255-A9AC02E5-C115-4026-8AA5-04D335F53971 Q30381121-F89E4901-C03B-48F1-877F-56DEAD31601D Q33288803-95F6AB66-302F-4F47-B056-C0A60D502F30 Q33577644-6E7BA19E-7688-4D69-9DE8-C41BFDBF103F Q33735938-4CA0511E-DFDD-40F6-8D21-20D96B3EFA08 Q33935130-DDA9C494-D2AC-4123-96ED-83F6164F36F7 Q34056468-36479CEB-642E-484C-9988-788B1853FE75 Q34079451-F1BF13FA-CA95-474B-B56A-AFDB03E5792B Q34137872-B444287F-6409-422D-91D4-EB5A2376B8A7 Q34228578-6A6D8889-C712-4B46-B9C4-F7BC4FF7836C Q34575173-D0EFDCDC-5238-4245-8F8A-18724BF037FB Q34857971-F8C29834-AE2E-4BA7-9D7F-B1044962696E Q35093088-A1D84C7A-CC16-41CE-831E-B2880E470CD3 Q35112897-F7F3F6D1-91E5-4E03-B1E1-214D93B98D7D Q35768345-8FB25AFB-DEC7-4553-99BF-4CA7F38E74B4 Q35930978-F73F77CA-7F3B-4F7D-9033-912580F7D81C Q36091442-5977C515-5060-41AE-80AF-ECD9BC25EEFF Q36268944-44BF3201-B1C4-4517-A370-291021A4F02B Q36387714-F6278CF0-6D59-499C-BD72-82A5929199CA Q36638121-479B77A9-4DD0-4E6C-9193-AE3494710185 Q36751963-97C3BA01-D6CE-44CC-9CC4-BB5B56627336 Q36844727-D5910E5C-18CB-4F2B-97A3-233A04CB9AD8 Q36903847-21CF392B-92D5-48AB-BA8F-CA1511AFF466 Q36974218-859AA593-63C7-4467-A73F-698B58D5D225 Q37007407-117B4BF6-26A2-45AC-A1B6-E32F561ED3DF Q37062509-F3C14E1D-965A-4650-9EF6-1A0E999A6D24 Q37101840-28451711-244D-4FDC-A4CB-F8DE31684D78 Q37150520-E718D67F-7965-445A-910A-84BE424A28E7 Q37423513-4AF38C71-F65B-427D-8520-857CE6CB705E Q37501981-B1DAF326-2912-4837-9916-A6FEB0C136DE Q37588538-10427B8C-82F6-42A8-9F64-7AEC345F2921 Q37974076-FE4E388A-4774-4F77-8AA9-861C74DB9113 Q38125279-FE4CFEDE-C4FC-441D-87D8-D9CB899D0E7F Q38134049-2E73B5EB-331D-4B25-A911-42C561D03E09 Q38238017-C94B929E-F1B2-4D35-BDF6-19C4B88CD2A2

P2860

SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis

http://www.wikidata.org/entity/Q34123761

description

2010 nî lūn-bûn

@nan

2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis

@ast

SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis

@en

SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis

@nl

type

label

SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis

@ast

SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis

@en

SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis

@nl

prefLabel

SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis

@ast

SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis

@en

SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis

@nl

P1433

Q34123761-ABD9A1DF-1C41-4D11-8CDD-45EAF96D7006

P1476

Q34123761-72295761-5E11-4E3B-B398-25BBBF62AEE4

P2093

Q34123761-07C73D2A-A76B-4B69-8943-EA605B4BAC20

Q34123761-1913FB0C-9BC4-48C6-BC3C-057348F9BF04

Q34123761-3D715239-ECFE-4587-92C9-BF9B40472581

Q34123761-61B0F6EE-DD98-49C9-906B-209DE43F3160

Q34123761-844AC885-7619-4579-95F9-F0F761F288F9

Q34123761-972F3BEA-A42C-4077-B50F-D6D9235BF626

Q34123761-98F1706C-B93C-47C4-82B0-634A02EBEE82

Q34123761-C04560BF-62F9-4A7A-A51D-099AECD14975

Q34123761-C79BC619-9424-454C-B0E4-7D6E3C6E7623

Q34123761-D4B2D205-DA62-4616-8FD6-7BA0D2207C67

P2860

Q34123761-05A4A93F-92C4-438D-B3B6-586FCAECC501

Q34123761-07EE4560-E50D-475F-9CF2-77D458517EB4

Q34123761-09608CD3-E3FF-4052-A45A-81C4E7414252

Q34123761-09A64A05-F21D-46EC-B964-D9D67EC58022

Q34123761-192681D8-5FB8-4F67-B131-43568880D6C0

Q34123761-19964DF8-52F8-4B57-BF64-C12671D88A07

Q34123761-1A3DDA4B-F59B-45A0-AA6F-D2C007BC2052

Q34123761-2199267A-5494-490A-801F-98449E70CCE3

Q34123761-234D625F-1DF8-40ED-90AB-C57FD369ECEE

Q34123761-290E3089-61F0-43FF-B6BB-167F0C037B18

P304

Q34123761-682BB0DF-3B21-4CF0-91BF-9971BEFFA845

P31

Q34123761-0AF61E5F-375B-4EB5-911A-C6991DD8B20F

P356

Q34123761-4AF6D64A-4C8E-4AAB-A398-E02296A19E5E

P433

Q34123761-F9A69648-3A8A-4A9E-A5C8-105BA8E85046

P478

Q34123761-552B31DC-6185-4F6A-9744-627858C2785B

P50

Q34123761-03F0FF05-505F-4EFE-A4DC-DBA25EBA18E8

Q34123761-1F8D0F2E-A63E-4042-AB2B-68AB4EDD0907

Q34123761-2EB2EC8B-D9B0-4547-8E07-6C449A370325

P577

Q34123761-D0088159-BF76-4280-AE12-563260C7118A

P5875

Q34123761-3BB3AB70-7B6C-44FE-B466-0147DCB1A73F

P698

Q34123761-53DB28A4-FA07-4884-875A-ADDA8850AE90

P932

Q34123761-C6BF4C25-4DD8-4BE2-A9A1-C335FDF0746F

P356

P1433

European Heart Journal

P1476

SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis

@en

P2093

Burkhard Becher

http://www.w3.org/2001/XMLSchema#string

Christian Besler

http://www.w3.org/2001/XMLSchema#string

Christian M Matter

http://www.w3.org/2001/XMLSchema#string

Christine Lohmann

http://www.w3.org/2001/XMLSchema#string

Janin Hofmann

http://www.w3.org/2001/XMLSchema#string

Karin M Rothgiesser

http://www.w3.org/2001/XMLSchema#string

Lucia Rohrer

http://www.w3.org/2001/XMLSchema#string

Michael O Hottiger

http://www.w3.org/2001/XMLSchema#string

Michael W McBurney

http://www.w3.org/2001/XMLSchema#string

Nicola Schäfer

http://www.w3.org/2001/XMLSchema#string

P2860

Negative control of p53 by Sir2alpha promotes cell survival under stress

hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase

Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase.

Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma

SIRT1 deacetylates and positively regulates the nuclear receptor LXR

Macrophage-specific inhibition of NF-kappaB activation reduces foam-cell formation

Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase

The mammalian SIR2alpha protein has a role in embryogenesis and gametogenesis

The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms

Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes

P304

2301-2309

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/EURHEARTJ/EHQ107

http://www.w3.org/2001/XMLSchema#string

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

Thomas Lüscher

P577

2010-04-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

43342762

http://www.w3.org/2001/XMLSchema#string

P698

20418343

http://www.w3.org/2001/XMLSchema#string

P932

2938465

http://www.w3.org/2001/XMLSchema#string